Literature DB >> 11004102

Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation.

W L Membrey1, D P Poinoosawmy, C Bunce, F W Fitzke, R A Hitchings.   

Abstract

AIM: To compare the frequency and site of visual field progression and changes in visual acuity in patients with normal pressure glaucoma (NPG) with and without pre-existing visual field loss.
METHOD: Patients with normal tension glaucoma were selected who had at least 10 visual fields over 5 or more years of follow up and no other condition that might influence the visual field or visual acuity. Alternate left and right eyes were selected from patients in random order. These eyes were then subdivided according to visual field defect threatening fixation, visual field defect not threatening fixation, and no visual field defect (fellow eyes). Eyes were defined as showing a threat to fixation according to the presence of a visual field defect involving one of more of four paracentral visual field locations. Pointwise linear regression analysis was applied to each visual field series using PROGRESSOR software. Progression of visual field loss was defined as the appearance of a regression slope 1 dB per year or more with a significance of p<0.01, which remained consistent with the addition of two of three successive visual fields to the series. The number of patients showing progression and the number where progression occurred in one of the four paracentral visual field locations was noted. The number of eyes losing two or more lines of Snellen visual acuity over the follow up period was also noted.
RESULTS: 174 eyes of 174 patients were selected. 106 eyes had visual field loss threatening fixation, 46 eyes had visual field loss that did not threaten fixation, and 22 were fellow eyes with normal visual fields. The median follow up was 7.2 years. Eight eyes (36.4%) in the "normal visual fields" group, 31 eyes (67.4%) in the "visual field loss away from fixation" group, and 87 eyes (82.1%) in the "threat to fixation" group showed progression in any part of the visual field. Two eyes (9.1%) in the "normal visual fields" group, nine eyes (19.6%) in the "visual field loss away from fixation" group, and 45 eyes (42.5%) in the "threat to fixation" group showed progression at "threat to fixation". The Cox proportional hazards regression model showed an increased risk of progression at any part of the visual field for female sex and a decreased risk for eyes with normal visual fields. For progression at threat to fixation this model showed an increased risk with pre-existing threat to fixation. Eyes from older patients and those that went on to have progressive visual field loss at fixation were more likely to lose two lines of Snellen visual acuity over the follow up period.
CONCLUSION: Since 20-30% of previously field damaged eyes and over 60% without prior field loss fail to demonstrate progressive visual field damage over a long follow up it is recommended that normal pressure glaucoma patients be monitored for progression and that potentially harmful therapy be withheld until progression is demonstrated. Although the presence of visual field loss that threatens fixation does not constitute an increased risk of visual field progression it does indicate an increased risk of further loss of visual field close to fixation which is in turn associated with loss of central acuity. In the light of this finding, patients with visual field loss that threatens fixation should be managed more aggressively.

Entities:  

Mesh:

Year:  2000        PMID: 11004102      PMCID: PMC1723256          DOI: 10.1136/bjo.84.10.1154

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  19 in total

Review 1.  Normal tension glaucoma--a practical approach.

Authors:  D Kamal; R Hitchings
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

2.  Visual field change in low-tension glaucoma over a five-year follow-up.

Authors:  R E Gliklich; W C Steinmann; G L Spaeth
Journal:  Ophthalmology       Date:  1989-03       Impact factor: 12.079

3.  The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study.

Authors:  I Dielemans; J R Vingerling; R C Wolfs; A Hofman; D E Grobbee; P T de Jong
Journal:  Ophthalmology       Date:  1994-11       Impact factor: 12.079

4.  Prevalence of glaucoma in the west of Ireland.

Authors:  M Coffey; A Reidy; R Wormald; W X Xian; L Wright; P Courtney
Journal:  Br J Ophthalmol       Date:  1993-01       Impact factor: 4.638

5.  Comparison of visual field defects in the low-tension glaucomas with those in the high-tension glaucomas.

Authors:  J Caprioli; G L Spaeth
Journal:  Am J Ophthalmol       Date:  1984-06       Impact factor: 5.258

6.  Visual field defects in normal-tension and high-tension glaucoma.

Authors:  M Araie; J Yamagami; Y Suziki
Journal:  Ophthalmology       Date:  1993-12       Impact factor: 12.079

7.  Patterns of early visual field loss in open-angle glaucoma.

Authors:  J Caprioli; M Sears; J M Miller
Journal:  Am J Ophthalmol       Date:  1987-04-15       Impact factor: 5.258

8.  Central function and visual field damage in glaucoma.

Authors:  B J Lachenmayr; S M Drance
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

9.  Visual field defects in patients with normal-tension glaucoma and patients with high-tension glaucoma.

Authors:  J H Zeiter; D H Shin; M S Juzych; T S Jarvi; T C Spoor; F Zwas
Journal:  Am J Ophthalmol       Date:  1992-12-15       Impact factor: 5.258

10.  Visual prognosis in advanced glaucoma: a comparison of medical and surgical therapy for retention of vision in 101 eyes with advanced glaucoma.

Authors:  A E Kolker
Journal:  Trans Am Ophthalmol Soc       Date:  1977
View more
  10 in total

1.  Frequency of testing for detecting visual field progression.

Authors:  S K Gardiner; D P Crabb
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

2.  Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss.

Authors:  Aakriti Garg; C Gustavo De Moraes; George A Cioffi; Christopher A Girkin; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill; Jeffrey M Liebmann
Journal:  Am J Ophthalmol       Date:  2018-01-06       Impact factor: 5.258

3.  Pharmacologic and pharmacokinetic assessment of anti-TGFbeta2 aptamers in rabbit plasma and aqueous humor.

Authors:  Thomas G McCauley; Jeffrey C Kurz; Patricia G Merlino; Scott D Lewis; Madaline Gilbert; David M Epstein; H Nicholas Marsh
Journal:  Pharm Res       Date:  2006-01-19       Impact factor: 4.200

Review 4.  Detection of visual field progression in glaucoma with standard achromatic perimetry: a review and practical implications.

Authors:  Kouros Nouri-Mahdavi; Nariman Nassiri; Annette Giangiacomo; Joseph Caprioli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-26       Impact factor: 3.117

5.  Impact of intraocular pressure reduction on visual field progression in normal-tension glaucoma followed up over 15 years.

Authors:  Shinya Oie; Kyoko Ishida; Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2017-05-26       Impact factor: 2.447

6.  Measurement of macular ganglion cell layer and circumpapillary retinal nerve fiber layer to detect paracentral scotoma in early glaucoma.

Authors:  Jeongmin Lee; Masanori Hangai; Yugo Kimura; Kohei Takayama; Changwon Kee; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-26       Impact factor: 3.117

7.  Refinement of pointwise linear regression criteria for determining glaucoma progression.

Authors:  Colleen M Kummet; K D Zamba; Carrie K Doyle; Chris A Johnson; Michael Wall
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-19       Impact factor: 4.799

8.  Enhanced Physiological Stress Response in Patients with Normal Tension Glaucoma during Hypoxia.

Authors:  Line Marie Dalgaard; Jeppe Vibæk; Rupali Vohra; Lars Thorbjørn Jensen; Barbara Cvenkel; Niels H Secher; Niels Vidiendal Olsen; Miriam Kolko
Journal:  J Ophthalmol       Date:  2021-04-07       Impact factor: 1.909

9.  Defective angles of localized retinal nerve fiber layer reflect the severity of visual field defect- a cross-sectional analysis.

Authors:  Alexander Chen; Ing-Chou Lai; Wan-Hua Cho; Hung-Yin Lai; Pei-Wen Lin; Pei-Chang Wu; Ming-Tse Kuo
Journal:  BMC Ophthalmol       Date:  2020-04-09       Impact factor: 2.209

10.  Rates of visual field progression in clinical glaucoma care.

Authors:  Anders Heijl; Patricia Buchholz; Gunilla Norrgren; Boel Bengtsson
Journal:  Acta Ophthalmol       Date:  2012-10-16       Impact factor: 3.761

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.